Purchase Order 75D30123P17643
Award Date
9/20/23
Potential Completion Date
9/28/24
Potential Value
$97K
Federal Agency
CDC Pittsburgh
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract worth $246,699.00 to Genscript USA Inc., a for-profit biotechnology company. The contract is for the synthesis of plasmids and mutagenesis in support of research on critical vaccine viruses (CVV), with a completion date of September 22, 2024. Genscript, based in Piscataway, New Jersey, provides a range of molecular biology services to federal agencies,...
Genscript USA Inc. was awarded a $90,340 purchase order by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. Under the terms of the contract, Genscript will provide bulk antibody production services in support of the CDC's CVV (Comparative Vaccine Vector) program. Performance will take place at Genscript's facility in Chamblee, Georgia over the course of one year, from September 2022 through September 2023. The contract has a firm fixed price and no set-aside...
This $227,348.40 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of focused antibodies and DNA to support the CDC's Influenza Division in the development and characterization of Candidate Vaccine Viruses (CVVs) for influenza pandemic preparedness. This requirement is driven by the constant genetic changes in circulating and novel...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing. The contract has a potential value of $174,903.00 and a completion date of July 14, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services, which it has...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, to provide protein antigen production for coronavirus vaccine antigens in support of COVID-19 research. The $139,989.48 contract has a completion date of September 23, 2022. Genscript has previously received federal awards from agencies such as the USDA to...
This is a $54,900 firm fixed-price purchase order awarded to Genscript USA Inc., a biotechnology company based in New Jersey, by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia. The contract is for the delivery of "AM MAG QUATTRO" products, with a period of performance through September 29, 2024. Genscript is a well-established provider of molecular biology services to various federal agencies, including the Department of Health and Human Services, Department...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing, custom design chimeric plasmid, and custom proteins. The $249,785.00 contract has a completion date of September 29, 2022 and was awarded on September 30, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to GenScript USA Inc., a biotechnology company based in New Jersey. The contract is for the supply of synthetic DNA sequences for cell culture expression of monoclonal antibodies to mumps virus, with a ceiling value of $75,024.01 and a period of performance through April 28, 2020. The award was made using a sole-source authority, as the government determined GenScript was the only source...
This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $248,857.00 Firm Fixed Price purchase order to Genscript USA Inc., a biotechnology company, for the provision of "FAST GENE SYNTHESIS" services. The contract has an August 7, 2023 completion date and was awarded on August 8, 2022. Genscript is a for-profit organization that provides gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services to...